Acceder

Threshold Pharmaceuticals, Inc (THLD): Opiniones

12,3K respuestas
Threshold Pharmaceuticals, Inc (THLD): Opiniones
2 suscriptores
Threshold Pharmaceuticals, Inc (THLD): Opiniones
Página
1.494 / 1.539
#11945

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

Completado reclutamiento de pacientes

Threshold Pharmaceuticals' Partner Merck KGaA, Darmstadt, Germany, Completes Target Enrollment in the TH-302 Phase 3 MAESTRO Study in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/03/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD), today announced that Threshold's partner Merck KGaA, Darmstadt, Germany, through its biopharmaceutical division, has completed target enrollment of 660 patients in the global Phase 3 MAESTRO

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#11947

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

¿Cómo vamos de pasta?

Estos no los paga Merck:

Preclinical and Phase 1 clinical data suggest that plasma concentrations of Hypoxin that are active in EGFR-dependent tumor xenograft models in mice could be attained in patients with an acceptable therapeutic index. Accordingly, the Company plans to conduct preclinical translational studies to further evaluate the rationale for proceeding with further clinical development of the compound. Subject to the satisfactory completion of these preclinical studies, the Company expects to initiate a Phase 2 proof-of-concept study in a subset of molecularly-defined non-small cell lung cancer patients who the Company believes may be responsive to Hypoxin in the first half of 2015

«Después de nada, o después de todo/ supe que todo no era más que nada.»

#11948

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

Report Q3

Threshold Pharmaceuticals misses by $0.03, misses on revenue • 7:05 AM
Gaurav Batavia, SA News Editor
Threshold Pharmaceuticals (NASDAQ:THLD): Q3 EPS of -$0.15 misses by $0.03.
Revenue of $3.68M (+15.7% Y/Y) misses by $0.14M.

http://seekingalpha.com/pr/11529685-threshold-pharmaceuticals-reports-third-quarter-2014-financial-and-operational-results?app=n

 

 

NOTE 2 — NET INCOME (LOSS) PER COMMON SHARE

http://www.conferencecalltranscripts.org/summary2/?id=1233811

#11950

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

un run up toca antes de la dilución ¿no?

#11951

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

framus .... y si puede ser , en "cristiano" que significa ??? ...que tu sabes que aqui hay muchos que faltaron a clase esos dias ... :-) ....estoy viendo esto Pre-Market : 3.80 Up 0.87 (+29.69%)

http://finance.yahoo.com/q?s=THLD

gracias

#11952

Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones

THLD
sólo 1100 acciones.....

Te puede interesar...
  1. Primeras dudas sobre la 'Trumponomics', ¿corrección o toma de beneficios?